Urinary neutrophil gelatinase-associated lipocalin (NGAL) can potentially predict vascular complications and reliably risk stratify patients with peripheral arterial disease
Abstract Neutrophil gelatinase-associated lipocalin (NGAL) is expressed in atherosclerotic plaques and implicated in the development of cardiovascular diseases. Peripheral arterial disease (PAD) is an atherosclerotic disease that often results in major cardiovascular events. This study aimed to pros...
Main Authors: | Mehroz Ehsan, Muzammil H. Syed, Abdelrahman Zamzam, Niousha Jahanpour, Krishna K. Singh, Rawand Abdin, Mohammad Qadura |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-12286-2 |
Similar Items
-
Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease
by: Ben Li, et al.
Published: (2022-06-01) -
Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
by: Ben Li, et al.
Published: (2022-06-01) -
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Patients with Obstructive Sleep Apnea.
by: Manish R Maski, et al.
Published: (2016-01-01) -
Neutrophil gelatinase-associated lipocalin (NGAL): Diagnostic Technology Update
by: Pluddemann, A, et al.
Published: (2016) -
Neutrophil gelatinase-associated lipocalin (NGAL) in lupus nephritis and beyond
by: Elisabet Svenungsson, et al.
Published: (2025-01-01)